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Abstract
A im s—To evaluate the performance of an 
immunoperoxidase stain using the mono­
clonal antibody EB-A1 to detect Aspergil­
lus species in formalin fixed, paraffin wax 
embedded tissue.
M ethods—The monoclonal antibody 
EB-A1 directed against galactomannan 
was used to detect Aspergillus species in 
23 patients with suspected or confirmed 
invasive aspergillosis. Immuno staining 
was performed on formalin fixed) paraffin 
wax embedded tissue using the strept- 
avidin-biotin method and compared with 
conventional haematoxylin and eosin, pe­
riodic acid-Schiff, and Gomori-Grocott 
stains. Results o f immuno staining were 
sem i quantitatively analysed with regard 
to both intensity o f staining and number of 
positively staining micro-organisms. Tis­
sue sections from 16 patients with con­
firm ed invasive mycoses due to Candida 
species3 Apophysornyces elegans> Rhizo- 
p u s  oryzae , Pseudallescheria boydii and 
H istoplasm a capsulatum  were used as 
controls.
R esults—In 19 (83%) of 23 cases invasive 
aspergillosis was confirmed by both histo­
logical examination and culture (18 As­
pergillus fum igatus  and one A flavus). 
Immunoperoxidase stains were positive in 
17 (89%) o f 19 cases including one case of 
dissem inated infection due to A flavus . 
Furthermore, the immunoperoxidase 
stain was positive in a culture negative tis­
sue section with histological evidence of 
m ycelial development, indicating the 
presence o f Aspergillus species. Some 
cross-reactivity was observed with the 
highly related fungus P boydii, although 
the number o f mycelial elements that 
stained was low.
Conclusions—Immunoperoxidase stain­
ing using the monoclonal antibody EB-A1 
performs well on routinely processed 
tissue sections and permits detection and 
generic identification of Aspergillus spe­
cies* although it was no better than 
conventional histopathology in identifying 
the presence of an infection. An additional 
advantage is that the immunostain may 
help to provide an aetiological diagnosis 
when cultures remain negative.
CJ Clin Pathol 1996;49:798-801)
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Aspergillus species can cause severe pulmonary 
infections in immunocompromised patients.1 
The antemortem diagnosis of invasive aspergil­
losis is difficult and3 although new sensitive 
diagnostic methods are being evaluated, 2-4 a 
definitive aetiological diagnosis can be made 
only by the demonstration of tissue invasion by 
fungal mycelium and a positive culture with 
morphological identification of Aspergillus spe­
cies. The diagnosis of invasive aspergillosis by 
histological examination of tissue sections 
alone is not reliable., because numerous fila­
mentous fungi cannot be differentiated from 
Aspergillus organisms with any of the com­
monly used fungal stains. A correct aetiological 
diagnosis, however, is important for the 
management of systemic mycoses and for the 
study of fungal epidemiology. Furthermore, 
the necessity for an aetiological diagnosis will 
increase because new fungal pathogens, such 
as Acremonium and Alternaría species, 5 6 have 
been reported to cause invasive infections in 
immunocompromised patients. To obtain a 
rapid and accurate generic identification, both 
poly- 7 and monoclonal7-10 antibodies have been 
used for direct immunoperoxidase staining of 
tissue sections. Previous observations have 
suggested that the monoclonal antibody 
EB-A1 directed against galactomannan was 
useful in the diagnosis of infections resulting 
from Aspergillus species.8 11 In this study we 
evaluated the performance of this monoclonal 
antibody to detect and identify Aspergillus spe­
cies in tissue sections obtained from patients 
with invasive mycoses.
Methods
Between 1989 and 1991 pathology and micro­
biology records from University Hospital 
Nijmegen were reviewed for consecutive 
necropsy cases with invasive aspergillosis. In 
each case identified the medical records were 
reviewed for clinical and radiological evidence 
of invasive aspergillosis. Tissue sections were 
also obtained from patients with confirmed 
invasive infections due to other filamentous 
fungi and Candida species* in order to evaluate 
the specificity of the immunoperoxidase stain.
All tissue specimens were fixed in 10% 
formalin solution, and processed to paraffin 
wax. Wax sections (4 |Lim) were cut for conven­
tional stain techniques including haematoxylin 
and eosin, periodic acid-Schiff (PAS), Gomori’s 
methenamine silver (GMS), and immunohisto- 
chemistry. Immunohistochemical staining was 
performed using the streptavidin-biotin-
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Table 1 Clinical characteristics of 23 patients with invasive aspergillosis and results o f histologys culture and immunohistochemistry
Case No Sex/age Underlying disease Aspergillus infection Histology Culture Im  munoperoxidase 
( n u m b er/intens ity)
1 M/41 Myelodysplastic
syndrome
Disseminated Fungi + A  fumigatus •f + + + /  + +  4-
2 M/51 ALL Disseminated Fungi + A  fumigatus + + +  + / +  +  4*
3 F/1.5 Pearson’s syndrome Disseminated Fungi + A  fumigatus} C albicans + + +  + /  + +  +
4 F/66 Grawitz’ s tumour Disseminated Fungi + A  fumigatus + + +  + /  + +  +
5 M/72 AML Disseminated Fungi + A fumigatus + +  +  + /  + +  +
6 F/45 AML, BMT Disseminated Fungi + ■ A  fumigatus 4— h 4* +  / 4* 4- 4*
7 F/29 SLE Disseminated Fungi + A  fiavus H— h 4- 4- / 4- +  -H
8 M/60 AML Lung Fungi + A fumigatus, Rhizopus 
rnicrosporus var. rhizopodiformis
+ H— H4~/+*f*  +
9 F/15 Agammaglobulinaemia Lung Fungi + A fumigatus
10 M/58 AML Lung Fungi + A  fumigatus
11 M/51 CML Lung Fungi + Negative + + +  +  / +  +  +
12 M/32 AML Lung Fungi + A fumigatus 4- + +  / + + +
13 M/59 Adenocarcinoma lung Lung Fungi + A fumigatus + + + / + + +
14 F/15 NHL, BMT Lung Fungi + A fumigatus + + + / + + +
15 M /l l CGD Lung Fungi + A fumigatus + + + / + + +
16 M/57 Hepatocellular
carcinoma
Lung Fungi + A fumigatus + + + /  + + 4*
17 M/60 Myelodysplastic
syndrome
Lung Fungi + A  fumigatus 4- + +  + /  + +  +
18 M/58 AML Lung Fungi + A  fumigatus + + + / + + +
19 F/44 AML, BMT (2x) Lung Fungi + A fumigatus H— h +  /  + + +
20 M/29 AML Lung Fungi + A fumigatus + +  +  + /  + +  +
21 M/61 HL Lung Fungi - A fumigatus _
22 M/55 Rheumatoid arthritis, 
kidney transplant
Lung Fungi - A  fumigatus
23 M/50 AML Lung Fungi - A  fumigatus
ALL = acute lymphoblastic leukaemia; AML = acute myeloblastic leukaemia; BM T = bone marrow transplantation; SLE = systemic lupus erythematosus; CM L 
chronic myeloid leukaemia; N H L  = non-Hodgkin’s lymphoma; CGD = chronic granulomatous disease; HL = Hodgkin’s lymphoma.
peroxidase complex method. In short, sections 
were cut and rehydrated* endogenous peroxi­
dase activity was blocked (by incubation in 1 % 
H20 2)* after which sections were incubated for 
20 minutes in normal goat serum (diluted 1 in 
5 in phosphate buffered saline (PBS)). The 
slides were then incubated with 20 (.ig/ml of the 
primary antibody (EB-A1* Eco-Path Aspergil­
lus* San.ofi Diagnostics Pasteur* Marnes-La- 
Coquette* France) for 60 minutes at room 
temperature. As a detection system* we used 
Multilink I (BioGenex* San Ramon* Califor­
nia* USA) followed by streptavidin-peroxidase 
conjugate (BioGenex). As a chromogen* we 
used a diaminobenzedine solution containing 
0.65% imidazol. The staining was intensified 
by incubation in 0.5% CUSO4 and 0.9% NaCl 
for five minutes. Finally* sections were weakly 
counterstained with Mayer’s haematoxylin* 
dehydrated* and mounted. As a negative
control* sections were incubated with PBS
instead of the primary antibody.
Tissue sections were examined for the pres­
ence of the characteristic brown staining and 
semiquantitatively evaluated by estimating the 
number of stained mycelial elements in the fol­
lowing categories: no staining and only a few 
scattered positive elements (less than 5%) (-); 
staining in 5% to 25% of elements (+); staining 
in 25 to 50% (+ +); staining in 50% to 75% 
(+ + +); and staining in 75% to 100% 
(+ + + +). The intensity was graded on a scale 
of -  to + + + : absence of staining (-); mild 
staining (+); moderate staining (+ +); and 
intense staining (+ + +). Equivocal reactions 
were considered negative. Furthermore* any 
background staining including non-specific 
staining of cells or tissues was noted separately. 
All slides were scored independently by three 
of the authors (PV* FS* JM).
Results
A total of 40 tissue sections from 39 patients 
with either suspected or necropsy confirmed 
invasive fungal infection was studied. Twenty 
three patients had either confirmed or sus­
pected infection with Aspergillus species. The 
clinical characteristics of these patients and the 
results of histology* culture and immunoper- 
oxidase staining are shown in table 1. In 19 of 
23 patients there was evidence of disease based 
on histopathology and culture* including seven 
patients with disseminated infection (cases 1 to 
7). All tissue sections obtained from the 
patients with disseminated infection showed 
intense hyphal immunostaining (number/ 
intensity: + + + + / + + +) (fig 1A), including 
one patient with A  flavus infection (case 7). 
One patient (case 8) with acute myeloblastic 
leukaemia died of respiratory insufficiency* and 
invasive pulmonary aspergillosis was diagnosed 
at necropsy. The presence of Aspergillus species 
was confirmed by both culture and immu- 
noperoxidase stain. In tiiis patient histological 
examination of a pulmonary thrombus showed 
hyphal elements. Culture yielded Rhizopus 
rnicrosporus variant rhizopodiformis and the 
immunostaining was negative. Another patient 
(case 11) with chronic myeloid leukaemia died 
of septicaemia and respiratory insufficiency. At 
necropsy a bronchopneumonia was diagnosed 
in the lower lobe of the left lung with mycelial 
elements demonstrated using the GMS stain. 
Although cultures remained negative* the 
immunostaining identified Aspergillus species.
A total of 18 (90%) of 20 tissue sections with 
mycelial development stained positively by die 
immunoperoxidase method. In three patients 
(cases 21 to 23) bronchopneumonia was diag­
nosed at necropsy but* although culture of the 
lung tissue yielded A  fumigatus* mycelial
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Figure } hmnunostaining of formalin fixedj paraffin wax embedded tissue sections using the streptavidin-biotin method and the monoclonal antibody 
BB-Al. The sections -were weakly counterstained with Mayer’s haematoxylin, (A) Aspergillus fumigatus in lung tissue ('+ + + + / + + +J. (B) 
Apophysomyces elegans in necrotic bone tissue (~ I —) t counterstained with Mayer’s haematoxylin, (C) Rhizopus oryzae in lung tissue. No 
immuno staining (— ( ~)9 counterstained with Mayer’s haematoxylin highlights fungal elements. (D) Pseudallescheria boydii in lung tissue (+ / +); some 
fungal elements show cross-reactive immunostaining. (Original magnification x400.)
elements could not be detected by conven­
tional fungal staining. Immunostaining was 
also absent in all three patients*
The cross-reactivity of the monoclonal anti­
body EB-A1 was tested by staining tissue 
sections obtained from 16 patients with 
non-Aspergillus mycoses (table 2)s including 12 
patients with histopathological and culture 
confirmed invasive candidiasis* a patient with 
pulmonary pseudallescheriasis, 12 a patient with 
A  elegans osteomyelitis of the humeral bone3 13 
a patient with a Rhizopus oryzae bronchopneu­
monia, and a patient with a disseminated 
Histoplasma capsulatum infection. No cross­
reactive immunostaining was observed with 
Candida species3 A  elegans (fig IB (—/ —))> R 
oryzae (fig 1C ( - / - ) )  and H  capsulatum. 
Immunostaining was observed in P boydii myc­
elial elements (fig ID (+ / +))3 although most 
elements showed no reactivity. Background 
staining was observed to be mild in infections 
in which there was frank necrosis, and did not
Table 2 Histological findings, microbiological identification, number of cases and sites of
involvement of 16 control patients with invasive non-Aspergillus mycoses
hamper the detection of the micro-organisms. 
In vital lung tissue cross-reactivity of the 
antibody was observed in epithelial cells lining 
the alveoli and in alveolar macrophages. 
Immunostaining in these specimens was some­
times quite intense, but mycelial elements were 
easily identified on die basis of their very 
different morphology. The immunostain was 
not better than conventional fungal staining for 
identifying the presence of an infection.
Histological
examination
Culture No of cases Sites of infection
Pseudo hyphae Candida spp* 12 Disseminated 6; lung 5; tongue 1
Mycelial elements Zygomycetesf 2 Lung 1; humerus 1
Mycelial elements Pseudallescheria boydii 1 Lung
Yeast form Histoplasma capsulatum 1 Disseminated
*Including C albicans (10 cases), C tropicalis (one case)3 and C parapsilosis (ane case), 
flncluding Apophysomyces elegans and Rhizopus oryzac.
Discussion
An accurate identification of fungal elements in 
tissue sections using conventional fungal stains 
requires considerable knowledge of fungal 
morphology, and remains difficult when based 
on morphological features alone. This is 
particulary difficult for histopathologists who 
are usually not familiar with fungal morphol­
ogy. The histological differentiation of Aspergil­
lus species from Fusarium3 Acremonium, Scopu- 
lariopsis, Trichoderma} Blastoschizomyces species 
and P boydii is particularly difficult as these 
fungi may induce similar clinical features and 
exhibit filamentous development in host tissue. 
Although subtle morphological features, such 
as dichotomous branching at 45° of Aspergillus 
mycelium, may help to differentiate this fungus 
from other filamentous fungi, only a presump­
tive diagnosis can be made when cultures 
remain negative. Inimunohistochemistry using 
mono- or polyclonal antibodies capable of
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detecting specific fungi in tissue sections is 
helpful in this respect/ ' 11 14 A drawback, 
however, is that only genera of fungi can be dif­
ferentiated. An advantage of immunostaining 
is that formalin fixed, paraffin wax embedded 
sections are used and that the staining method 
is relatively easy to perform. In the present 
study immunoperoxidase staining with EB-A1 
proved useful for the generic identification of 
Aspergillus species in tissue sections. The pres­
ence of Aspergillus organisms was confirmed in 
17 of 19 culture positive tissue sections, and in 
one patient fungal mycelium was identified as 
Aspergillus species in a culture negative tissue 
section. Cross-reactivity with three Candida 
species, two Zygomycete species, and H  capsu- 
latum was not observed.
An important factor in the evaluation of any 
immunohistochemical method is the estima­
tion of background staining in relation to posi­
tively staining micro-organisms, We did note 
low levels of background staining in proteina- 
cious oedema fluid in the lungs and also some­
times in exudates as well as in alveolar macro­
phages, The levels of background staining were 
low and usually did not deter identification of 
the fungi. In some cases, however, macro­
phages did show higher levels of immunostain­
ing, reflecting the high concentrations of 
endogenous peroxidases within these cells; 
again this staining did not make fungal identi­
fication more difficult.
Immunofluorescence studies have shown 
that Aspergillus, Fusarium, and P boydii are anti- 
genically closely related.15 Previous observa­
tions indicated that the monoclonal antibody 
EB-A1 does not cross-react with Fusarium spe­
cies/ but the reactivity with P boydii was not 
ascertained. Our results suggest that EB-A1 
can also differentiate Aspergillus organisms 
from P boydii. Although some cross-reactive 
staining occurred with the P boydii hyphae, the 
intensity of immunostaining was low and most 
elements were not stained. The monoclonal 
antibody EB-A1 cross-reacts with Penicillium 
marneffei 814 which has some immunodomi­
nant epitopes in the cell wall which are identi­
cal with those of Aspergillus species.16 Invasive 
infections with both Aspergillus species 17 and P  
marneffei18 have been reported in patients with 
AIDS, and therefore the monclonal antibody 
EB-A1 cannot be used to differentiate these 
fungi. As the tissue form of P marneffei 
develops as a yeast-like structure, 19 differentia­
tion from Aspergillus species can be made by 
histological examination with conventional 
fungal stains. However, histological examin­
ation should be interpreted with caution 
because elongated forms or filamentous devel­
opment of P marneffei have been reported to 
occur in the stratum corneum of the skin, 14 in 
liver and lung tissue specimens of a patient 
with AIDS,20 and in pulmonary cavities.19
In conclusion, immunoperoxidase staining 
with EB-A1 in formalin fixed and paraffin wax 
embedded tissue is very helpful in providing 
proof of an Aspergillus infection and excluding 
certain other fungal genera, but is not better 
than conventional histopathology in identifying 
the presence of an infection. The results should 
be interpreted in the whole clinical context of 
the patient, because false negative results and 
cross-reactivity with P marneffei and P boydii 
may occur.
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